These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11376567)

  • 1. Suicide gene therapy for chemically induced rat bladder tumor entailing instillation of adenoviral vectors.
    Akasaka S; Suzuki S; Shimizu H; Igarashi T; Akimoto M; Shimada T
    Jpn J Cancer Res; 2001 May; 92(5):568-75. PubMed ID: 11376567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential gene transfer to BBN-induced rat bladder tumor by simple instillation of adenoviral vector.
    Shimizu H; Akasaka S; Suzuki S; Akimoto M; Shimada T
    Urology; 2001 Mar; 57(3):579-84. PubMed ID: 11248651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium].
    Wang B; Weng J
    Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):618-22. PubMed ID: 12487913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model.
    Cheon J; Moon DG; Cho HY; Park HS; Kim JJ; Gardner TA; Kao C
    Int J Urol; 2002 May; 9(5):261-7. PubMed ID: 12060439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massive apoptotic cell death in chemically induced rat urinary bladder carcinomas following in situ HSVtk electrogene transfer.
    Shibata MA; Horiguchi T; Morimoto J; Otsuki Y
    J Gene Med; 2003 Mar; 5(3):219-31. PubMed ID: 12666188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer.
    Tang W; He Y; Zhou S; Ma Y; Liu G
    J Exp Clin Cancer Res; 2009 Dec; 28(1):155. PubMed ID: 20015348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer.
    Yin X; Yu B; Tang Z; He B; Ren J; Xiao X; Tang W
    Cancer Gene Ther; 2013 Feb; 20(2):77-81. PubMed ID: 23258087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
    Sutton MA; Berkman SA; Chen SH; Block A; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Woo SL; Lerner SP
    Urology; 1997 Feb; 49(2):173-80. PubMed ID: 9037277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.
    Sutton MA; Freund CT; Berkman SA; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Lerner SP
    Mol Ther; 2000 Sep; 2(3):211-7. PubMed ID: 10985951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential histopathological changes in vivo after suicide gene therapy of gastric cancer induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats.
    Okino T; Onda M; Matsukura N; Inada KI; Tatematsu M; Suzuki S; Shimada T
    Jpn J Cancer Res; 2001 Jun; 92(6):673-9. PubMed ID: 11429057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J; Chen Y; Li H; Lu Y; Yan Y; Tan X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
    Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
    Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma].
    Tan WL; Xie Y; Wu YD; Zhu WH; Zheng SB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):594-7. PubMed ID: 16762858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.
    Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A
    Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.